ZZürich Read More ETH Zurich scientists developed a new drug to slow Alzheimer’s development2026-06-10 Alzheimer’s disease slowly strips brain cells of the energy they need to survive. However, one damaged enzyme may…
NNovartis Read More SciNeuro and Novartis Enter into a Licensing and Collaboration Agreement for Next Generation Therapeutics to Treat Alzheimer’s Disease2026-03-15 ROCKVILLE, Md. , Jan. 12, 2026 /PRNewswire/ — SciNeuro Pharmaceuticals Logo (PRNewsfoto/SciNeuro Pharmaceuticals) SciNeuro grants Novartis an exclusive worldwide…